Cytotoxic T lymphocyte antigen 4 is induced in the thymus upon in vivo activation and its blockade prevents anti-CD3-mediated depletion of thymocytes

Journal of Experimental Medicine

Volumn 188, Issue 7, 1998, Pages 1239-1246

  Cilio, Corrado M ^a   Daws, Michael R ^a   Malashicheva, Anna ^a,b   Sentman, Charles L ^a   Holmberg, Dan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

CD28; Costimulation; Cytotoxic T lymphocyte antigen 4 (CD152); T cell development; Tyrosine phosphatase SHP 2

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOREGULATION; LYMPHOCYTE DEPLETION; MOUSE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION; APOPTOSIS; IMMUNOCONJUGATES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; PROTEIN-TYROSINE-PHOSPHATASE; SHP1 PROTEIN TYROSINE PHOSPHATASE; THYMUS GLAND;

EID: 0032487574     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.7.1239     Document Type: Article

References (41)

1. von Boehmer, H. 1992. Thymic selection: a matter of life and death. Immunol. Today. 13:454-458.
2. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93-126.
3. Kisielow, P., and A. Miazek. 1995. Positive selection of T cells: rescue from programmed cell death and differentiation require continual engagement of the T cell receptor. J. Exp. Med. 181:1975-1984.
4. Kisielow, P., and H. von Boehmer. 1995. Development and selection of T cells: facts and puzzles. Adv. Immunol. 58:87-209.
5. Chambers, C.A., and J.P. Allison. 1997. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9:396-404.
6. Thompson, C.B., and J.P. Allison. 1997. The emerging role of CTLA-4 as an immune attenuator. Immunity. 7:445-450.
7. Waterhouse, P., L.E. Marengere, H.W. Mittrucker, and T.W. Mak. 1996. CTLA-4, a negative regulator of T-lymphocyte activation. Immunol. Rev. 153:183-207.
8. Walunas, T.L., D.J. Lenschow, C.Y. Bakker, P.S. Linsley, G.J. Freeman, J.M. Green, C.B. Thompson, and J.A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:405-413.
9. Krummel, M.F., and J.P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459-465.
10. Krummel, M.F., and J.P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533-2540.
11. Gross, J.A., E. Callas, and J.P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:380-388.
12. Linsley, P.S., W. Brady, M. Urnes, L.S. Grosmaire, N.K. Damle, and J.A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-569.
13. Linsley, P.S., J.L. Greene, W. Brady, J. Bajorath, J.A. Ledbetter, and R. Peach. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity. 1:793-801.
14. Kariv, I., A. Truneh, and R.W. Sweet. 1996. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function. J. Immunol. 157: 29-38.
15. Alegre, M.L., P.J. Noel, B.J. Eisfelder, E. Chuang, M.R. Clark, S.L. Reiner, and C.B. Thompson. 1996. Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J. Immunol. 157:4762-4770.
16. Linsley, P.S., J. Bradshaw, J. Greene, R. Peach, K.L. Bennett, and R.S. Mittler. 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity. 4:535-543.
17. Nelson, A.J., S. Hosier, W. Brady, P.S. Linsley, and A.G. Farr. 1993. Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro. J. Immunol. 151:2453-2461.
18. + thymocytes. J. Immunol. 152:3254-3263.
19. Amsen, D., and A.M. Kruisbeek. 1996. CD28-B7 interactions function to co-stimulate clonal deletion of double-positive thymocytes. Int. Immunol. 8:1927-1936.
20. + thymocytes by T cell receptor-induced apoptosis requires a co-stimulatory signal that can be provided by CD28. J. Exp. Med. 179:709-713.
21. Kishimoto, H., and J. Sprent. 1997. Negative selection in the thymus includes semimature T cells. J. Exp. Med. 185:263-271.
22. Perez, V.L., L. Van Parijs, A. Biuckians, X.X. Zheng, T.B. Strom, and A.K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 6: 411-417.
23. + T cells from tolerance induction by the superantigen staphylococcal enterotoxin B. Eur. J. Immunol. 26:858-862.
24. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.
25. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:985-988.
26. Wagner, D.H., Jr., J. Hagman, P.S. Linsley, W. Hodsdon, J.H. Freed, and M.K. Newell. 1996. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/ CTLA-4 costimulatory interactions with B7-1/B7-2. J. Exp. Med. 184:1631-1638.
27. Chambers, C.A., D. Cado, T. Truong, and J.P. Allison. 1997. Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA. 94:9296-9301.
28. Waterhouse, P., M.F. Bachmann, J.M. Penninger, P.S. Ohashi, and T.W. Mak. 1997. Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur. J. Immunol. 27:1887-1892.
29. Brunet, J.F., F. Denizot, M.F. Luciani, M. Roux Dosseto, M. Suzan, M.G. Mattei, and P. Golstein. 1987. A new member of the immunoglobulin superfamily - CTLA-4. Nature. 328: 267-270.
30. Scollay, R., A. Wilson, and K. Shortman. 1984. Thymus cell migration: analysis of thymus emigrants with markers that distinguish medullary thymocytes from peripheral T cells. J. Immunol. 132:1089-1094.
31. Smith, C.A., G.T. Williams, R. Kingston, E.J. Jenkinson, and J.J. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature. 337:181-184.
32. Marengere, L.E., P. Waterhouse, G.S. Duncan, H.W. Mittrucker, G.S. Feng, and T.W. Mak. 1996. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science. 272:1170-1173.
33. Qu, C.K., Z.Q. Shi, R. Shen, F.Y. Tsai, S.H. Orkin, and G.S. Feng. 1997. A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development. Mol. Cell. Biol. 17:5499-5507.
34. Kharitonenkov, A., Z. Chen, I. Sures, H. Wang, J. Schilling, and A. Ullrich. 1997. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature. 386:181-186.
35. Liu, Y. 1997. Is CTLA-4 a negative regulator for T-cell activation? Immunol. Today. 18:569-572.
36. Garchon, H.J., P. Bedossa, L. Eloy, and J.F. Bach. 1991. Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice. Nature. 353:260-262.
37. Nistico, L., R. Buzzetti, L.E. Pritchard, B. Van der Auwera, C. Giovannini, E. Bosi, M.T. Larrad, M.S. Rios, C.C. Chow, C.S. Cockram, et al. 1996. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 5: 1075-1080.
38. Badenhoop, K., H. Donner, J. Braun, T. Siegmund, H. Rau, and K.H. Usadel. 1996. Genetic markers in diagnosis and prediction of relapse in Graves' disease. Exp. Clin. Endocrinol. Diabetes. 4:98-1110.
39. Marron, M.P., L.J. Raffel, H.J. Garchon, C.O. Jacob, M. Serrano-Rios, M.T. Martinez Larrad, W.P. Teng, Y. Park, Z.X. Zhang, D.R. Goldstein, et al. 1997. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum. Mol. Genet. 6: 1275-1282.
40. Kotsa, K., P.F. Watson, and A.P. Weetman. 1997. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin. Endocrinol. 46:551-554.
41. Donner, H., H. Rau, P.G. Walfish, J. Braun, T. Siegmund, R. Finke, J. Herwig, K.H. Usadel, and K. Badenhoop. 1997. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 82:143-146.